Pune, Oct. 17, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Tuberculosis (TB) Diagnostic market by Type (Culture and Species Identification, Radiographic Test, Microscopy, Molecular Testing, Antigen Testing, Genetic Testing, and Drug Resistance Test) and by End User (Hospitals & Clinics and Diagnostic Laboratories) - Global Outlook & Forecast 2022-2030 " published by Growth Plus Reports, the tuberculosis diagnostics market is expected to grow at a CAGR of 4.10% from 2021 to reach US$ 2.58 billion by 2030. The global tuberculosis diagnostics market is driven by government initiatives, increasing awareness about tuberculosis, and a high incidence rate of tuberculosis. However, the high cost of the genome and molecular testing hinders the growth of global tuberculosis (TB) diagnostics market.
Get a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/tuberculosis-(tb)-diagnostics-market/7878
Excerpts from 'Competitive Landscape'
The prominent players operating in the global tuberculosis diagnostics market are
- Thermo Fisher Scientific Inc
- Abbott Laboratories Inc
- Becton
- Dickinson and Company
- BioMérieux SA
- Danaher Corporation
- F. Hoffmann-La Roche Ltd
- Hain Lifescience GmbH
- Hologic Inc
- Oxford Immunotec
- QIAGEN NV
Growth Drivers
Tuberculosis is the world's 13th leading cause of death and the world's second most infectious and dangerous disease after covid-19. Tuberculosis is preventable and treatable if diagnosis and treatment are made in the early stages. According to the World Health Organization, In October 2021, nearly 1.5 million people died because of tuberculosis (TB) among 214000 people who had HIV. Around 10 million people are diagnosed with tuberculosis (TB) worldwide, out of 1.1. million were children, 5.6 million were men, and 3.3 million were women.
Tuberculosis (TB) is a highly infectious and contagious disease caused by mycobacterium tuberculosis bacteria (MTB); tuberculosis mycobacteria usually attack the lungs and then spread to any body part, i.e., gland, bones, organs, nervous system, etc. Tuberculosis (TB) spreads through droplets in the air via sneezes and coughs from an infected person. Common symptoms of tuberculosis are coughing up blood or sputum (mucus), breathlessness, pain in the chest, high fever, fatigue or weakness, night sweats, and sudden weight loss. Many tests are available for diagnosing tuberculosis (TB), viz., radiographic examination, culture, and sensitivity test, molecular testing, microscopy test, drug resistance test, and genetic sequencing.
The global tuberculosis diagnostics market has been analyzed from five perspectives: type, technology, end-user, and region.
Excerpts from 'By Product'
The global tuberculosis diagnostics market has been segmented into:
- Radiographic Tests
- Microscopy
- Molecular Testing
- Culture
- Species Identification
- Antigen Testing
- Drug Resistance
- Genetic Testing
Molecular testing is leading the global tuberculosis diagnostic market owing to its shorter turnaround time, high sensitivity, technological advancement, and high specificity. Due to early detection, genetic testing is also expected to proliferate in the coming years. Precise diagnosis and genome testing are highly recommended by the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO).
Speak to our Analyst to Understand the Impact of COVID-19 on Your Business: https://growthplusreports.com/inquiry/speak-analyst/tuberculosis-(tb)-diagnostics-market/7878
Tuberculosis (TB) Diagnostics Market by End User
Based on end-users, the global tuberculosis (TB) diagnostics market has been segmented into:
- Hospitals & Clinics
- Diagnostic Laboratories
Hospitals and clinics critically analyze patients' primary symptoms and prescribe confirmatory tests. Due to the high patient footfall for diagnosis and treatment, hospitals and clinics are leading global tuberculosis (TB) diagnostics market.
Excerpts from 'By Region Segmentation'
The global tuberculosis diagnostics market has been segmented into:
- North America
- Europe
- Asia Pacific
- Rest of the World
North America dominated the global tuberculosis (TB) diagnostics market, followed by the Asia Pacific. The large share of North America in the worldwide market can be attributed to the swift adoption of technologically advanced solutions, the presence of developed infrastructure, high expenditure on healthcare, and the adoption of novel technology for the diagnosis of tuberculosis (TB). The Asia Pacific is also expected to show exponential growth owing to its large population, increasing prevalence of tuberculosis and awareness about tuberculosis, developing infrastructure, and emerging diagnostics companies. Government initiatives for tuberculosis diagnosis and free treatment also contribute to the Asia Pacific tuberculosis (TB) diagnostics market.
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Directly Purchase Premium Copy of Tuberculosis Diagnostics Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=52uvU1ftATrEtKmdmsTOlXPdF2y3XQ9CR03J99ZE&report_id=7878&license=Single
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
